BackOrion Biotech Opportunities - Warrants (15/04/2025) Overview

Orion Biotech Opportunities - Warrants (15/04/2025) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for ORIAW.

Quarterly EBIT

-$203.52K
18.63% YoY

As of Dec 31, 2022

Annual EBIT (TTM)

-$899.67K
43.21% YoY

Trailing 12 months ending Dec 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)